| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $11.4M | $8.3M | $6.8M |
| YoY Revenue Growth % | +36.6% | +21.5% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $553.6M | $284.6M | $635.0M |
| Operating Margin % | 4872.9% | 3421.5% | 9279.7% |
| Net Income (GAAP) | $377.7M | $89.6M | $444.4M |
| EBITDA (Normalized) | $554.0M | $284.9M | $635.3M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $902.9M | $876.8M | $832.7M |
| Capital Expenditures (CapEx) | $511.2K | $374.3K | $307.9K |
| Free Cash Flow (FCF) | $902.4M | $876.5M | $832.4M |
| FCF Margin % | 7942.7% | 10538.3% | 12163.6% |
| Return on Invested Capital (ROIC %) | 7.1% | 3.5% | 13.3% |
| Cash & Short-Term Equivalents | $1.2M | $1.3M | — |
| Total Debt (Short + Long Term) | $2.91B | $2.90B | $1.46B |
| Total Stockholders' Equity | $3.29B | $3.44B | $3.00B |